Literature DB >> 8500566

Experimental autoimmune anterior uveitis (EAAU). III. Induction by immunization with purified uveal and skin melanins.

R M Broekhuyse1, E D Kuhlmann, H J Winkens.   

Abstract

The pathogenicity of uveal tissue and melanin has been a controversial subject for a long time. The present new approach has elucidated some of the problems. Melanin granules have been extracted from bovine choroid, iris, hair and skin, and from human, monkey and rabbit choroid. The melanin granules have further been purified by detergent extractions, and are free from pathogenic retinal antigens. Lewis rats immunized with microgram doses bovine choroidal or iris melanin-protein (in Freund's complete adjuvant or Hunter's adjuvant, combined with pertussis toxin) develop severe experimental autoimmune anterior uveitis (EAAU). No retinitis or pinealitis is found. The other melanins are weakly uveitogenic or inactive. The relative pathogenicity of the various melanins seems to be related to tissue and species specificity. The responsible hypothetic pathogenic structure UP-X (uveal pathogen X) is highly stable and resists proteolytic digestion by various enzymes. Its pathogenic activity is destroyed by hot 6 N HCl or longlasting 0.5 N NaOH treatment. In view of its chemical and immunological features it is probably identical to the pathogen PEP-X of bovine retinal pigment epithelial melanin. UP-X-induced EAAU can be transferred by spleen cells, and is suppressed by cyclosporin showing that a T-cell-mediated pathogenic mechanism predominates. It resembles human anterior uveitis by its specific location, its transient nature, and sparing of the retina. In these respects EAAU differs from retinal photoreceptor antigen-induced forms of EAU where retinitis with photoreceptor damage is a main feature. The involvement of melanin in human ocular diseases is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8500566     DOI: 10.1006/exer.1993.1071

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  7 in total

1.  Apoptosis is a prominent feature of acute anterior uveitis in the Fischer 344 rat.

Authors:  J R Smith; P H Hart; S D Standfield; D J Coster; S J Wing; K A Williams
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

Review 2.  Interpreting melanin-based coloration through deep time: a critical review.

Authors:  Johan Lindgren; Alison Moyer; Mary H Schweitzer; Peter Sjövall; Per Uvdal; Dan E Nilsson; Jimmy Heimdal; Anders Engdahl; Johan A Gren; Bo Pagh Schultz; Benjamin P Kear
Journal:  Proc Biol Sci       Date:  2015-08-22       Impact factor: 5.349

3.  Experimental melanin-induced uveitis in the Fischer 344 rat is inhibited by anti-CD4 monoclonal antibody, but not by mannose-6-phosphate.

Authors:  J R Smith; P H Hart; C R Parish; S D Standfield; D J Coster; K A Williams
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

Review 4.  Uveitis: Molecular Pathogenesis and Emerging Therapies.

Authors:  Charles E Egwuagu; Sahar A Alhakeem; Evaristus C Mbanefo
Journal:  Front Immunol       Date:  2021-04-30       Impact factor: 7.561

5.  Multifocal choroiditis following simultaneous hepatitis A, typhoid, and yellow fever vaccination.

Authors:  Sarah Escott; Ahmad B Tarabishy; Frederick H Davidorf
Journal:  Clin Ophthalmol       Date:  2013-02-18

6.  Identification of Ocular Autoantigens Associated With Juvenile Idiopathic Arthritis-Associated Uveitis.

Authors:  Martin Busch; Kira Leona Wefelmeyer; Karoline Walscheid; Kai Rothaus; Dirk Bauer; Cornelia A Deeg; Roxane L Degroote; Doreen Ackermann; Simone König; Solon Thanos; Maren Kasper; Arnd Heiligenhaus
Journal:  Front Immunol       Date:  2019-08-06       Impact factor: 7.561

Review 7.  Drug-induced uveitis: A review.

Authors:  Manisha Agarwal; Parthopratim Dutta Majumder; Kalpana Babu; Vinaya Kumar Konana; Mallika Goyal; Sara Touhami; Dinu Stanescu-Segall; Bahram Bodaghi
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.